Parp Inhibitors
Parp Inhibitor Latest News

Parp Inhibitor News

The West Clinic Ramps Up Clinical Trials
The West Clinic will be doing more early-stage clinical trials so its doctors can prescribe and test cancer drugs straight from the discovery lab....

PARP Inhibitor Adds Chemo Option
A novel agent that inhibits DNA repair in cancer cells appears to be promising for safety and efficacy given along with chemotherapy using irinotecan (Camptosar), according to early-phase clinical trial results reported here....

Novel PARP Inhibitor Shows Efficacy
A novel PARP inhibitor appeared to have anti-tumor activity in advanced cancer patients with BRCA1/2 mutations, but also in some without, researchers said...

Cancer treatment gets a boost with medical breakthroughKLTV
... a way to rebuild, get healthy again... and start growing again." Dr. Gross says PARP inhibitors keeps those potentially cancerous, potentially deadly cells, from repairing themselves; even the most ...

Breakthrough Breast Cancer Research Centre Pioneering Work Leads To Patient Trial Of New Generation Cancer Drug Medical News Today
... repair of DNA. A cell with a BRCA fault relies on a protein called PARP to keep its DNA healthy. Olaparib, known as a 'PARP-inhibitor', blocks PARP, which causes ...

New Cancer Treatment Curbs Side Effects, wbztv.com
... it stopped working. With few options doctors gave him an experimental drug called a PARP inhibitor. Today he is doing well and his cancer, caused by a genetic mutation, ...

PARP Inhibitors Shrink Certain TumorsDrug Discovery ... Development - June 25, 2009
Just-released research about a new class of drugs called PARP inhibitors is the most exciting development in cancer research in a decade or more. ...

New Hope for Cancer Treatment NBC Chicago
... A new class of drugs called PARP inhibitors may be the most exciting development in cancer research in a decade or ...

Useful Links:


Cancer Directory
Add Your URL FREE, Boost Your Web Site's Traffic & Rankings.
Web Directory - www.cancerzone.org

 

Comment About Parp Inhibitors